Skip to main content
. 2023 Jul 31;29(8):2133–2141. doi: 10.1038/s41591-023-02465-7

Extended Data Fig. 3. All occurrence of nausea and vomiting in the safety analysis set.

Extended Data Fig. 3

Individual data points are reported in Supplementary Tables 5 and 6. aThe onset day in the onset interval was defined as the date of onset minus the date of first dose plus 1. CAPOX, capecitabine plus oxaliplatin regimen.